Want to join the conversation?
During 2Q16, $MYL's Generic segment third-party sales rose 4% to $2.14Bil vs. 2Q15. Specialty segment third-party net sales rose 33% vs. 2Q15, helped by higher unit volumes and realization of the benefits of customer contract negotiations related to EpiPen Auto-Injector, as well as higher sales of the Perforomist Inhalation Solution and ULTIVA.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.